|
1
|
Hardingham T: Extracellular matrix and
pathogenic mechanisms in osteoarthritis. Curr Rheumatol Rep.
10:30–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wilusz RE, Sanchez-Adams J and Guilak F:
The structure and function of the pericellular matrix of articular
cartilage. Matrix Biol. 39:25–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bian Q, Wang YJ, Liu SF and Li YP:
Osteoarthritis: genetic factors, animal models, mechanisms, and
therapies. Front Biosci (Elite Ed). 4:74–100. 2012. View Article : Google Scholar
|
|
4
|
Daheshia M and Yao JQ: The interleukin
1beta pathway in the pathogenesis of osteoarthritis. J Rheumatol.
35:2306–2312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hwang HS, Park IY, Kim DW, Choi SY, Jung
YO and Kim HA: PEP-1-FK506BP12 inhibits matrix metalloproteinase
expression in human articular chondrocytes and in a mouse
carrageenan-induced arthritis model. BMB Rep. 48:407–412. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Burrage PS, Mix KS and Brinckerhoff CE:
Matrix metalloproteinases: role in arthritis. Front Biosci.
11:529–543. 2006. View
Article : Google Scholar
|
|
7
|
Hadler-Olsen E, Fadnes B, Sylte I,
Uhlin-Hansen L and Winberg JO: Regulation of matrix
metalloproteinase activity in health and disease. FEBS J.
278:28–45. 2011. View Article : Google Scholar
|
|
8
|
Berenbaum F: Signaling transduction:
target in osteoarthritis. Curr Opin Rheumatol. 16:616–622. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vincenti MP and Brinckerhoff CE:
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in
arthritis: integration of complex signaling pathways for the
recruitment of gene-specific transcription factors. Arthritis Res.
4:157–164. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sondergaard BC, Schultz N, Madsen SH,
Bay-Jensen AC, Kassem M and Karsdal MA: MAPKs are essential
upstream signaling pathways in proteolytic cartilage degradation -
divergence in pathways leading to aggrecanase and MMP-mediated
articular cartilage degradation. Osteoarthritis Cartilage.
18:279–288. 2010. View Article : Google Scholar
|
|
11
|
Mengshol JA, Vincenti MP, Coon CI,
Barchowsky A and Brinckerhoff CE: Interleukin-1 induction of
collagenase 3 (matrix metalloproteinase 13) gene expression in
chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear
factor kappaB: differential regulation of collagenase 1 and
collagenase 3. Arthritis Rheum. 43:801–811. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Studer R, Jaffurs D, Stefanovic-Racic M,
Robbins PD and Evans CH: Nitric oxide in osteoarthritis.
Osteoarthritis Cartilage. 7:377–379. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Farkouh ME, Greenberg JD, Jeger RV,
Ramanathan K, Verheugt FW, Chesebro JH, Kirshner H, Hochman JS, Lay
CL, Ruland S, et al: Cardiovascular outcomes in high risk patients
with osteoarthritis treated with ibuprofen, naproxen or
lumiracoxib. Ann Rheum Dis. 66:764–770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Herndon CM: Topical delivery of
nonsteroidal anti-inflammatory drugs for osteoarthritis. J Pain
Palliat Care Pharmacother. 26:18–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mobasheri A: Intersection of inflammation
and herbal medicine in the treatment of osteoarthritis. Curr
Rheumatol Rep. 14:604–616. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Wei S, Liu T, Pang J, Gao N, Ding
D, Duan T, Cao Y, Zheng Y and Zhan H: Effectiveness, medication
patterns, and adverse events of traditional chinese herbal patches
for osteoarthritis: a systematic review. Evid Based Complement
Alternat Med. 2014:3431762014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ann JY, Eo H and Lim Y: Mulberry leaves
(Morus alba L.) ameliorate obesity-induced hepatic lipogenesis,
fibrosis, and oxidative stress in high-fat diet-fed mice. Genes
Nutr. 10:462015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jo SP, Kim JK and Lim YH:
Antihyperlipidemic effects of stilbenoids isolated from Morus alba
in rats fed a high-cholesterol diet. Food Chem Toxicol. 65:213–218.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim HG, Jeong HU, Park G, Kim H, Lim Y and
Oh MS: Mori folium and mori fructus mixture attenuates high-fat
diet-induced cognitive deficits in mice. Based Complement Alternat
Med. 2015:3794182015.
|
|
20
|
Tirupathi RG, Suresh BK, Ujwal KJ, Sujana
P, Raoa AV and Sreedhar AS: Anti-microbial principles of selected
remedial plants from Southern India. Asian Pac J Trop Biomed.
1:298–305. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qin J, Fan M, He J, Wu XD, Peng LY, Su J,
Cheng X, Li Y, Kong LM, Li RT and Zhao Q: New cytotoxic and
anti-inflammatory compounds isolated from Morus alba L. Nat Prod
Res. 29:1711–1718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khan MA, Rahman AA, Islam S, Khandokhar P,
Parvin S, Islam MB, Hossain M, Rashid M, Sadik G, Nasrin S, et al:
A comparative study on the antioxidant activity of methanolic
extracts from different parts of Morus alba L. (Moraceae). BMC Res
Notes. 6:242013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deepa M, Sureshkumar T, Satheeshkumar PK
and Priya S: Antioxidant rich Morus alba leaf extract induces
apoptosis in human colon and breast cancer cells by the
downregulation of nitric oxide produced by inducible nitric oxide
synthase. Nutr Cancer. 65:305–310. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deepa M and Priya S: Purification and
characterization of a novel anti-proliferative lectin from Morus
alba L. leaves. Protein Pept Lett. 19:839–845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Enkhmaa B, Shiwaku K, Katsube T, Kitajima
K, Anuurad E, Yamasaki M and Yamane Y: Mulberry (Morus alba L.)
leaves and their major flavonol quercetin 3-(6-malonylglucoside)
attenuate atherosclerotic lesion development in LDL
receptor-deficient mice. J Nutr. 135:729–734. 2005.PubMed/NCBI
|
|
26
|
Sugimoto M, Arai H, Tamura Y, Murayama T,
Khaengkhan P, Nishio T, Ono K, Ariyasu H, Akamizu T, Ueda Y, et al:
Mulberry leaf ameliorates the expression profile of adipocytokines
by inhibiting oxidative stress in white adipose tissue in db/db
mice. Atherosclerosis. 204:388–394. 2009. View Article : Google Scholar
|
|
27
|
Lee YJ, Choi DH, Kim EJ, Kim HY, Kwon TO,
Kang DG and Lee HS: Hypotensive, hypolipidemic, and vascular
protective effects of Morus alba L. in rats fed an atherogenic
diet. Am J Chin Med. 39:39–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee H, Pyo MJ, Bae SK, Heo Y, Kim CG, Kang
C and Kim E: Improved Therapeutic Profiles of PLA2-Free Bee Venom
Prepared by Ultrafiltration Method. Toxicol Res. 31:33–40. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim BH, Oh I, Kim JH, Jeon JE, Jeon B,
Shin J and Kim TY: Anti-inflammatory activity of compounds isolated
from Astragalus sinicus L. in cytokine-induced keratinocytes and
skin. Exp Mol Med. 46:e872014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gebauer M, Saas J, Sohler F, Haag J, Söder
S, Pieper M, Bartnik E, Beninga J, Zimmer R and Aigner T:
Comparison of the chondrosarcoma cell line SW1353 with primary
human adult articular chondrocytes with regard to their gene
expression profile and reactivity to IL-1beta. Osteoarthritis
Cartilage. 13:697–708. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Toegel S, Wu SQ, Otero M, Goldring MB,
Leelapornpisid P, Chiari C, Kolb A, Unger FM, Windhager R and
Viernstein H: Caesalpinia sappan extract inhibits IL1β-mediated
overexpression of matrix metalloproteinases in human chondrocytes.
Genes Nutr. 7:307–318. 2012. View Article : Google Scholar :
|
|
32
|
Torzilli PA, Tehrany AM, Grigiene R and
Young E: Effects of misoprostol and prostaglandin E2 on
proteoglycan biosynthesis and loss in unloaded and loaded articular
cartilage explants. Prostaglandins. 52:157–173. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Amin AR, Attur M and Abramson SB: Nitric
oxide synthase and cyclooxygenases: distribution, regulation, and
intervention in arthritis. Curr Opin Rheumatol. 11:202–209. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wada Y, Shimada K, Sugimoto K, Kimura T
and Ushiyama S: Novel p38 mitogen-activated protein kinase
inhibitor R-130823 protects cartilage by downregulating matrix
metal-loproteinase-1,-13 and prostaglandin E2 production
in human chondrocytes. Int Immunopharmacol. 6:144–155. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park SJ, Cheon EJ and Kim HA: MicroRNA-558
regulates the expression of cyclooxygenase-2 and IL-1β-induced
catabolic effects in human articular chondrocytes. Osteoarthritis
Cartilage. 21:981–989. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lu YC, Jayakumar T, Duann YF, Chou YC,
Hsieh CY, Yu SY, Sheu JR and Hsiao G: Chondroprotective role of
sesamol by inhibiting MMPs expression via retaining NF-κB signaling
in activated SW1353 cells. J Agric Food Chem. 59:4969–4978. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rigoglou S and Papavassiliou AG: The NF-κB
signalling pathway in osteoarthritis. Int J Biochem Cell Biol.
45:2580–2584. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liacini A, Sylvester J, Li WQ, Huang W,
Dehnade F, Ahmad M and Zafarullah M: Induction of matrix
metalloproteinase-13 gene expression by TNF-alpha is mediated by
MAP kinases, AP-1, and NF-kappaB transcription factors in articular
chondrocytes. Exp Cell Res. 288:208–217. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Salvatierra J, Escames G, Hernandez P,
Cantero J, Crespo E, Leon J, Salvatierra D, Acuña-Castroviejo D and
Vives F: Cartilage and serum levels of nitric oxide in patients
with hip osteoarthritis. J Rheumatol. 26:2015–2017. 1999.PubMed/NCBI
|
|
40
|
Miyaura C, Inada M, Suzawa T, Sugimoto Y,
Ushikubi F, Ichikawa A, Narumiya S and Suda T: Impaired bone
resorption to prostaglandin E2 in prostaglandin E
receptor EP4-knockout mice. J Biol Chem. 275:19819–19823. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen WP, Wang YL, Tang JL, Hu PF, Bao JP
and Wu LD: Morin inhibits interleukin-1β-induced nitric oxide and
prostaglandin E2 production in human chondrocytes. Int
Immunopharmacol. 12:447–452. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Graham S, Gamie Z, Polyzois I, Narvani AA,
Tzafetta K and Tsiridis E, Helioti M, Mantalaris A and Tsiridis E:
Prostaglandin EP2 and EP4 receptor agonists in bone formation and
bone healing: in vivo and in vitro evidence. Expert Opin Investig
Drugs. 18:746–766. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sasaki K, Hattori T, Fujisawa T, Takahashi
K, Inoue H and Takigawa M: Nitric oxide mediates
interleukin-1-induced gene expression of matrix metalloproteinases
and basic fibroblast growth factor in cultured rabbit articular
chondrocytes. J Biochem. 123:431–439. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tung JT, Arnold CE, Alexander LH,
Yuzbasiyan-Gurkan V, Venta PJ, Richardson DW and Caron JP:
Evaluation of the influence of prostaglandin E2 on
recombinant equine interleukin-1beta-stimulated matrix
metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix
metalloproteinase 1 expression in equine chondrocyte cultures. Am J
Vet Res. 63:987–993. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Barchowsky A, Frleta D and Vincenti MP:
Integration of the NF-kappaB and mitogen-activated protein
kinase/AP-1 pathways at the collagenase-1 promoter: divergence of
IL-1 and TNF-dependent signal transduction in rabbit primary
synovial fibroblasts. Cytokine. 12:1469–1479. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
White LA and Brinckerhoff CE: Two
activator protein-1 elements in the matrix metalloproteinase-1
promoter have different effects on transcription and bind Jun D,
c-Fos, and Fra-2. Matrix Biol. 14:715–725. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Roman-Blas JA and Jimenez SA: NF-kappaB as
a potential therapeutic target in osteoarthritis and rheumatoid
arthritis. Osteoarthritis Cartilage. 14:839–848. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Itthiarbha A, Phitak T, Sanyacharernkul S,
Pothacharoen P, Pompimon W and Kongtawelert P: Polyoxypregnane
glycoside from Dregea volubilis extract inhibits IL-1β-induced
expression of matrix metalloproteinase via activation of NF-κB in
human chondrocytes. In Vitro Cell Dev Biol Anim. 48:43–53. 2012.
View Article : Google Scholar
|
|
49
|
Sunaga T, Oh N, Hosoya K, Takagi S and
Okumura M: Inhibitory effects of pentosan polysulfate sodium on
MAP-kinase pathway and NF-κB nuclear translocation in canine
chondrocytes in vitro. J Vet Med Sci. 74:707–711. 2012. View Article : Google Scholar : PubMed/NCBI
|
